Advocacy

Washington Update: ARPA-H Organizational Structure Established; Initial Leadership Positions Filled

The biomedical research system has historically been supported by two main pillars: fundamental research on the mechanisms of disease, largely funded by the National Institutes of Health (NIH), and the pharmaceutical industry, which creates products to treat these conditions. Recent advances in biomedical research and health sciences present an opportunity to change how we understand,... Read More

Capital Hill

Hill Day Reflections from the 2022 ACGT Advocates

On May 11, 2022, ASHG hosted its second (virtual) Capitol Hill Day. This event brought together 21 Society members from the ASHG Board of Directors, the Government and Public Advocacy Committee (GPAC), and trainee advocates from the Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program. ASHG advocates shared the value and progress of... Read More

The Importance of Advocacy as a Scientist

The Importance of Advocacy as a Scientist

Scientists are in the unique position to directly convey the benefits of human genetics and genomics research to policymakers. It is critical that we communicate the benefits of human genetics and genomics research to Congress because decisions happen on the Hill that affect research and the use of genetics-based technologies – with or without our... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy